RemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express

Yesterday

RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the related public disclosure.

The meeting will be chaired by Mr. Wang Weidong, who serves as chairman and executive director. The current board comprises four executive directors (Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian), two non-executive directors (Dr. Wang Liqiang, Dr. Su Xiaodi), and three independent non-executive directors (Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin).

The company is incorporated in the People’s Republic of China and remains committed to timely dissemination of its financial performance. Details of the unaudited first-quarter results will be published following board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1174576271"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174576271\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174576271?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-16 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174576271","market":"hk","top_or_hot":-1,"title":"RemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results","media":"Bulletin Express","content":"<p>RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the related public disclosure.</p>\n<p>The meeting will be chaired by Mr. Wang Weidong, who serves as chairman and executive director. The current board comprises four executive directors (Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian), two non-executive directors (Dr. Wang Liqiang, Dr. Su Xiaodi), and three independent non-executive directors (Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin).</p>\n<p>The company is incorporated in the People’s Republic of China and remains committed to timely dissemination of its financial performance. Details of the unaudited first-quarter results will be published following board approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-16 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the related public disclosure.</p>\n<p>The meeting will be chaired by Mr. Wang Weidong, who serves as chairman and executive director. The current board comprises four executive directors (Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian), two non-executive directors (Dr. Wang Liqiang, Dr. Su Xiaodi), and three independent non-executive directors (Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin).</p>\n<p>The company is incorporated in the People’s Republic of China and remains committed to timely dissemination of its financial performance. Details of the unaudited first-quarter results will be published following board approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09995","symbol_name":"荣昌生物","start_time":0,"source_url":"","article_id":"1174576271","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174576271","pubTimestamp":1776330231,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09995":"荣昌生物"},"translate_title":"RemeGen计划于2026年4月28日召开董事会，审查2026年第一季度未经审计的业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09995":1},"content_text":"RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the related public disclosure.\nThe meeting will be chaired by Mr. Wang Weidong, who serves as chairman and executive director. The current board comprises four executive directors (Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian), two non-executive directors (Dr. Wang Liqiang, Dr. Su Xiaodi), and three independent non-executive directors (Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin).\nThe company is incorporated in the People’s Republic of China and remains committed to timely dissemination of its financial performance. Details of the unaudited first-quarter results will be published following board approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}